Company Encyclopedia
View More
name
AIDIGONG
00286.HK
Aidigong Maternal & Child Health Limited, an investment holding company, provides postpartum care and healthcare services in the People’s Republic of China. The company operates through Postpartum Care Services, Health Industry, and Other segments. It offers maternal and child healthcare services; medical anti-aging services; healthcare industry investment services; and healthcare property development services, as well as management, investment, and finance services. The company was formerly known as Common Splendor International Health Industry Group Limited and changed its name to Aidigong Maternal & Child Health Limited in December 2019.
51.26 B
00286.HKMarket value -Rank by Market Cap -/-

Financial Score

09/12/2025 Update
D
Health Care ServicesIndustry
Industry Ranking25/28
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-24.35%E
    • Profit Margin-36.96%E
    • Gross Margin25.54%C
  • Growth ScoreE
    • Revenue YoY-20.70%E
    • Net Profit YoY-51.37%D
    • Total Assets YoY-13.31%E
    • Net Assets YoY-18.74%E
  • Cash ScoreE
    • Cash Flow Margin-270.57%D
    • OCF YoY-20.70%E
  • Operating ScoreD
    • Turnover0.26D
  • Debt ScoreD
    • Gearing Ratio59.97%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Aidigong Maternal & Child Health Sets Special Shareholder Meeting After Requisition

    Aidigong Maternal & Child Health Limited will hold a special general meeting of shareholders by January 13, 2026, following a requisition notice. The Board is arranging the meeting per company Bye-laws and Listing Rules. Details will be in a circular to shareholders. Trading in shares remains suspended. Shareholders and investors should exercise caution. This announcement was made via the Hong Kong Stock Exchange's Issuer Information Service.

    Reuters·
    HK
    02943
    0.00%
    HK
    00286
    0.00%
    Reuters·
    HK
    02943
    0.00%
    HK
    00286
    0.00%

    Aidigong Maternal & Child Health Updates on Trading Resumption Efforts

    Aidigong Maternal & Child Health Limited has provided a quarterly update on its efforts to resume trading on the Hong Kong Stock Exchange. The company is addressing financial information issues for its 2024 audit, legal proceedings, and board composition to meet regulatory requirements. Aidigong is committed to resumption guidance and is working with professional advisers to formulate a viable plan.

    Tip Ranks·
    HK
    02943
    0.00%
    HK
    00286
    0.00%
    Tip Ranks·
    HK
    02943
    0.00%
    HK
    00286
    0.00%

    Aidigong Maternal & Child Health Receives Request to Convene Special Shareholder Meeting

    Aidigong Maternal & Child Health Limited has received a request from shareholders to convene a special general meeting. The meeting aims to discuss litigation updates, company governance, and the suspension of trading in the company's shares. The company will comply with regulations to proceed with the meeting.

    Reuters·
    HK
    02943
    0.00%
    HK
    00286
    0.00%
    Reuters·
    HK
    02943
    0.00%
    HK
    00286
    0.00%

    Yuzhou Group logs October sales RMB702 mln

    Yuzhou Group logs October sales RMB702 mln

    marketscreener·
    HK
    01628
    -10.16%
    HK
    00286
    0.00%
    HK
    02943
    0.00%
    marketscreener·
    HK
    01628
    -10.16%
    HK
    00286
    0.00%
    HK
    02943
    0.00%

    Yuzhou Group Reports RMB702 Million Sales and 55,488 sq.m. GFA Sold in October 2025

    Yuzhou Group Holdings Company Limited reported unaudited sales of RMB702 million and a gross floor area (GFA) of 55,488 square meters sold in October 2025. For the first ten months of 2025, total sales reached RMB5,615 million with a GFA of 396,947 square meters. The average selling price was RMB12,653 per square meter in October and RMB14,148 per square meter for the year-to-date. These figures are preliminary and subject to change in future financial statements.

    Reuters·
    HK
    01628
    -10.16%
    HK
    00286
    0.00%
    HK
    02943
    0.00%
    Reuters·
    HK
    01628
    -10.16%
    HK
    00286
    0.00%
    HK
    02943
    0.00%
    © 2025 Longbridge｜Disclaimer